Markets.com Logo

PROGEN

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.6353$
  • Previous Close
    0.6411$
  • 52 Week Change
    26.96$
  • Day Range
    -0.01$
  • 52 Week High/Low
    0.5$ - 27.4625$
  • Dividend Per Share
    --
  • Market cap
    22 792 K$
  • EPS
    -80
  • Beta
    0.2
  • Volume
    --

About

PROGEN.ST represents Progenics Biopharma Inc. shares traded on the Nasdaq Stockholm stock exchange. It's a biotech company focused on developing innovative medicines and diagnostics for oncology, with a particular emphasis on targeted therapeutics and molecular imaging. The "ST" at the end of the ticker symbol signifies that it is listed on the Nasdaq Stockholm exchange, allowing investors in Sweden and other European markets to trade shares of the company. Investors should conduct thorough research into Progenics Biopharma's financial performance, pipeline development, and market conditions before making any investment decisions.

UK and France: Economic Challenges and Speculation of IMF Intervention

Noah Lee|--

September Stock Market Outlook: Fed Rate Cut Uncertainty Looms

Emma Rose|--

AI Bull Market: Learning from the Dot-Com Bubble's Lessons?

Sophia Claire|--
Honest (HNST) Shares Analysis: What is the price forecast for HNST?

Honest (HNST) Shares Analysis: What is the price forecast for HNST?

Frances Wang|--
Energy stocks analysis: XOM is up, CVX is over $114, COP stock outlook

Energy stocks analysis: XOM is up, CVX is over $114, COP stock outlook

Frances Wang|--
 Snowflake Stock Is Down Today: What Is the Target Price for SNOW Stock

Snowflake Stock Is Down Today: What Is the Target Price for SNOW Stock

Ghko B|--

WLFI Token Launch: The Trump Family's Latest Crypto Venture

Emma Rose|--

Factors

Company Performance: Progenics Therapeutics operational and financial performance directly influences its stock. Positive clinical trial results, successful drug approvals, and strong revenue growth typically lead to stock price increases.

Market Sentiment: Overall investor sentiment towards the biotechnology sector and pharmaceutical industry affects PROGEN.ST. Optimism about industry growth prospects can drive up stock prices, while pessimism can depress them.

Regulatory Events: Regulatory decisions by health agencies, such as FDA, regarding Progenics' drugs significantly impact stock value. Approvals boost prices, while rejections or delays can cause declines.

Competition: The competitive landscape within the pharmaceutical market influences investor perception. Introduction of competing drugs or therapies can negatively affect PROGEN.ST if they pose a threat to Progenics' market share.

Macroeconomic Factors: Broader economic conditions, including interest rates, inflation, and economic growth, impact stock prices. Economic downturns can reduce investor risk appetite, leading to sell-offs in more volatile stocks like PROGEN.ST.

News and Events: Company-specific news, such as management changes, partnerships, or acquisitions, can cause fluctuations in stock price. Positive news typically boosts prices, while negative news can depress them.

Analyst Ratings: Recommendations from financial analysts influence investor decisions. Positive ratings and price targets can encourage buying, while negative ratings can lead to selling pressure.

Clinical Trial Outcomes: The outcomes of clinical trials for Progenics' drug candidates are major price catalysts. Successful trial results that demonstrate efficacy and safety often lead to significant stock price appreciation.

Patent Protection: The strength and duration of patent protection for Progenics' products are crucial for maintaining market exclusivity and profitability. Loss of patent protection or challenges to patents can negatively affect stock value.

Investor Expectations: The market's expectations for Progenics' future performance play a significant role. If the company fails to meet expectations, even with positive results, the stock price may decline.

People Also Watch

Latest news

US Congress Budget Showdown Looms: Potential Funding Standoff

Emma Rose|--

Russia Oil Discount Allures India Amid US Pressure to Reduce Trade

Ava Grace|--

Japan's Prime Minister Kishida Faces Pressure Amidst Election Losses

Emma Rose|--

Latest Education Articles

Crypto CFD Trading Basics: How to Trade XRP (Ripple's XRP-USD) CFDs?

Crypto CFD Trading Basics: How to Trade XRP (Ripple's XRP-USD) CFDs?

Frances Wang|--
Active Stocks CFD Trading: MRVL Stock, ADSK Stock, DELL, BABA

Active Stocks CFD Trading: MRVL Stock, ADSK Stock, DELL, BABA

Frances Wang|--
Crypto CFD trading platforms 2025: eToro, Plus500, AvaTrade, XTB

Crypto CFD trading platforms 2025: eToro, Plus500, AvaTrade, XTB

Frances Wang|--